Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases.
$22.39 +0.49 (2.24%)
As of 03/05/2021 15:59:49 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.